The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications

被引:63
作者
Jialal, Ishwarlal [1 ]
Kaur, Harmeet [1 ]
机构
[1] UC Davis Med Ctr, Lab Atherosclerosis & Metab Res, Sacramento, CA 95817 USA
关键词
Diabetes; T1DM; T2DM; TLR2; TLR4; Insulin resistance; Obesity; Inflammation; Vascular complications; Toll-like receptors; INNATE IMMUNE-SYSTEM; PATTERN-RECOGNITION; HUMAN MONOCYTES; GAMMA AGONIST; TLR LIGANDS; FATTY-ACIDS; EXPRESSION; ATHEROSCLEROSIS; DISEASE; MICE;
D O I
10.1007/s11892-012-0258-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes confers an increased risk for both microvascular and macrovascular complications. Numerous studies have reported increased levels of biomarkers of inflammation that could predispose to vascular complications. The pattern recognition receptors of the innate immune response, such as Toll-like receptors (TLRs), especially TLR2 and TLR4, have been incriminated in both atherosclerosis and insulin resistance. Studies have reported increased expression and activity of these receptors in both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus. Most recently, knockout of TLR2 has been shown to attenuate the proinflammatory state of T1DM and the progression of diabetic nephropathy. The increased activity of TLRs in diabetes could be the result of a conspiracy of both endogenous and exogenous ligands. Biomediators of increased TLR2 and TLR4 activity include tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-6, monocyte chemoattractant protein-1, and type 1 interferons. Modulating these TLRs could be beneficial in forestalling diabetic complications given the pivotal role of inflammation in both microvascular and macrovascular complications.
引用
收藏
页码:172 / 179
页数:8
相关论文
共 75 条
  • [1] HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
    Andersson, Ulf
    Tracey, Kevin J.
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, VOL 29, 2011, 29 : 139 - 162
  • [2] [Anonymous], 2011, National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States
  • [3] RAGE biology, atherosclerosis and diabetes
    Barlovic, Drazenka Pongrac
    Soro-Paavonen, Aino
    Jandeleit-Dahm, Karin A. M.
    [J]. CLINICAL SCIENCE, 2011, 121 (1-2) : 43 - 55
  • [4] Inferences, questions and possibilities in toll-like receptor signalling
    Beutler, B
    [J]. NATURE, 2004, 430 (6996) : 257 - 263
  • [5] Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways
    Björkbacka, H
    Kunjathoor, VV
    Moore, KJ
    Koehn, S
    Ordija, CM
    Lee, MA
    Means, T
    Halmen, K
    Luster, AD
    Golenbock, DT
    Freeman, MW
    [J]. NATURE MEDICINE, 2004, 10 (04) : 416 - 421
  • [6] Critical role of the NADPH oxidase subunit p47phox on vascular TLR expression and neointimal lesion formation in high-fat diet-induced obesity
    Chen, Jian-Xiong
    Stinnett, Amanda
    [J]. LABORATORY INVESTIGATION, 2008, 88 (12) : 1316 - 1328
  • [7] New Insights into the Regulation of Signalling by Toll-Like Receptors and Nod-Like Receptors
    Coll, Rebecca C.
    O'Neill, Luke A. J.
    [J]. JOURNAL OF INNATE IMMUNITY, 2010, 2 (05) : 406 - 421
  • [8] Cyclooxygenase 2 Inhibition Exacerbates Palmitate-Induced Inflammation and Insulin Resistance in Skeletal Muscle Cells
    Coll, Teresa
    Palomer, Xavier
    Blanco-Vaca, Francisco
    Carles Escola-Gil, Joan
    Sanchez, Rosa M.
    Laguna, Juan C.
    Vazquez-Carrera, Manuel
    [J]. ENDOCRINOLOGY, 2010, 151 (02) : 537 - 548
  • [9] Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes
    Creely, S. J.
    McTernan, P. G.
    Kusminski, C. M.
    Fisher, Ff. M.
    Da Silva, N. F.
    Khanolkar, M.
    Evans, M.
    Harte, A. L.
    Kumar, S.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 292 (03): : E740 - E747
  • [10] Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9
    Dandona, P
    Aljada, A
    Mohanty, P
    Ghanim, H
    Bandyopadhyay, A
    Chaudhuri, A
    [J]. DIABETES CARE, 2003, 26 (12) : 3310 - 3314